» Articles » PMID: 22433781

Bone Repair Cells for Craniofacial Regeneration

Overview
Specialty Pharmacology
Date 2012 Mar 22
PMID 22433781
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Reconstruction of complex craniofacial deformities is a clinical challenge in situations of injury, congenital defects or disease. The use of cell-based therapies represents one of the most advanced methods for enhancing the regenerative response for craniofacial wound healing. Both somatic and stem cells have been adopted in the treatment of complex osseous defects and advances have been made in finding the most adequate scaffold for the delivery of cell therapies in human regenerative medicine. As an example of such approaches for clinical application for craniofacial regeneration, Ixmyelocel-T or bone repair cells are a source of bone marrow derived stem and progenitor cells. They are produced through the use of single pass perfusion bioreactors for CD90+ mesenchymal stem cells and CD14+ monocyte/macrophage progenitor cells. The application of ixmyelocel-T has shown potential in the regeneration of muscular, vascular, nervous and osseous tissue. The purpose of this manuscript is to highlight cell therapies used to repair bony and soft tissue defects in the oral and craniofacial complex. The field at this point remains at an early stage, however this review will provide insights into the progress being made using cell therapies for eventual development into clinical practice.

Citing Articles

Recent advances in GTR scaffolds.

Bajpai D, Rajasekar A Bioinformation. 2023; 18(12):1181-1185.

PMID: 37701512 PMC: 10492908. DOI: 10.6026/973206300181181.


Craniofacial therapy: advanced local therapies from nano-engineered titanium implants to treat craniofacial conditions.

Gulati K, Ding C, Guo T, Guo H, Yu H, Liu Y Int J Oral Sci. 2023; 15(1):15.

PMID: 36977679 PMC: 10050545. DOI: 10.1038/s41368-023-00220-9.


Three-Dimensional Impression of Biomaterials for Alveolar Graft: Scoping Review.

Francisco I, Basilio A, Prata Ribeiro M, Nunes C, Travassos R, Marques F J Funct Biomater. 2023; 14(2).

PMID: 36826875 PMC: 9961517. DOI: 10.3390/jfb14020076.


A novel lineage of osteoprogenitor cells with dual epithelial and mesenchymal properties govern maxillofacial bone homeostasis and regeneration after MSFL.

Weng Y, Wang H, Wu D, Xu S, Chen X, Huang J Cell Res. 2022; 32(9):814-830.

PMID: 35821090 PMC: 9436969. DOI: 10.1038/s41422-022-00687-x.


Low-Intensity Pulsed Ultrasound Promotes Osteogenic Potential of iPSC-Derived MSCs but Fails to Simplify the iPSC-EB-MSC Differentiation Process.

Hua Z, Li S, Liu Q, Yu M, Liao M, Zhang H Front Bioeng Biotechnol. 2022; 10:841778.

PMID: 35656194 PMC: 9152674. DOI: 10.3389/fbioe.2022.841778.


References
1.
Wei G, Ma P . Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering. Biomaterials. 2004; 25(19):4749-57. DOI: 10.1016/j.biomaterials.2003.12.005. View

2.
Zouhary K . Bone graft harvesting from distant sites: concepts and techniques. Oral Maxillofac Surg Clin North Am. 2010; 22(3):301-16, v. DOI: 10.1016/j.coms.2010.04.007. View

3.
Ripamonti U, Reddi A . Tissue engineering, morphogenesis, and regeneration of the periodontal tissues by bone morphogenetic proteins. Crit Rev Oral Biol Med. 1997; 8(2):154-63. DOI: 10.1177/10454411970080020401. View

4.
Schaefer D, Martin I, Jundt G, Seidel J, Heberer M, Grodzinsky A . Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum. 2002; 46(9):2524-34. DOI: 10.1002/art.10493. View

5.
Hasegawa N, Kawaguchi H, Hirachi A, Takeda K, Mizuno N, Nishimura M . Behavior of transplanted bone marrow-derived mesenchymal stem cells in periodontal defects. J Periodontol. 2006; 77(6):1003-7. DOI: 10.1902/jop.2006.050341. View